On May 14, 2025, New York State hosted the third Annual Hepatitis C Elimination Progress Report virtual meeting to share progress toward reaching its elimination goals, as outlined in the 2021 release of the New York State Hepatitis C Elimination Plan. All of the materials and presentations from the May meeting are now available: Hepatitis C […]
Category Archives: Announcements
14
May
May
Newly released hepatitis C (HCV) elimination metrics on the HCV Dashboard show that in 2023, 4,783 people were newly diagnosed with HCV in New York State, an 8% decrease from 2022. HCV incidence also continued to decrease, with the rate of new HCV infections dropping from 4.0 to 3.6 new infections per 100,000 population among […]
30
Apr
Apr
This is a guest blog collaboration from the NYSDOH Bureau of Hepatitis Health Care and Epidemiology and the HCV Dashboard Team. New York State (NYS) recognizes May as Hepatitis Awareness Month. Hepatitis Awareness Month offers a chance to increase awareness of viral hepatitis transmission, celebrate the millions who have been cured of hepatitis C, and help reduce […]
21
Jan
Jan
Click to view full page flyer Sign up here
Announcements
Third Annual New York State Hepatitis C Elimination Progress Report Meeting and Abstract Submission
18
Nov
Nov
Dear Colleagues, The AIDS Institute Bureau of Hepatitis Health Care and Epidemiology is pleased to announce the third Annual New York State (NYS) Hepatitis C Elimination Progress Report Meeting will be held virtually from 10 am – 2 pm on May 14, 2025, in collaboration with the New York City Department of Health and Mental Hygiene. The theme of this year’s […]
31
Oct
Oct
We are excited to announce the forthcoming launch of the “STI Dashboard NY: New York State’s Sexual Health Dashboard” (https://stidashboardny.org)! Launching early in 2025, the purpose of the Dashboard is to promote and improve sexual health in New York State by providing a web-based, publicly accessible tool to explore sexually transmitted infection (STI) data. The Dashboard […]
29
Oct
Oct
In June of 2024, the United States (US) Food and Drug Administration (FDA) approved Cepheid’s GeneXpert (XpertⓇHCV) for Point of Care (POC) hepatitis C (HCV) diagnostic testing, the first of its kind for HCV in the US. The test is CLIA (Clinical Laboratory Improvement Amendment) waived, meaning the instrument is simple to use and with […]
19
Aug
Aug
This blog post contains edited excerpts from a press release originally published by the CUNY Graduate School of Public Health & Health Policy. A pioneering study sheds new light on the hepatitis C (HCV) virus epidemic among young people who inject drugs in New York City. This research, led by Drs. Honoria Guarino and Pedro […]
29
Jul
Jul
In 2022, the hepatitis C (HCV) infection rate among 18–40 year-olds in New York State (NYS) was 4.0 per 100,000 population, a 27% decrease from 5.5 new HCV infections per 100,000 in 2020. These data are now available as interactive visualizations along with HCV diagnoses and treatment/clearance data on the HCV Dashboard. Users can explore […]
06
Jun
Jun
On May 15, 2024, New York State hosted the second Annual Hepatitis C Elimination Progress Report virtual meeting to share progress toward reaching its elimination goals, as outlined in the 2021 release of the New York State Hepatitis C Elimination Plan. All of the materials and presentations from the May meeting are now available: Hepatitis […]